გასტროეზოფაგური რეფლუქსის დაავადება

Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan 1;117(1):27-56.სრული ტექსტი  აბსტრაქტი

Muthusamy VR, Lightdale JR, Acosta RD, et al; ASGE Standards of Practice Committee. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81(6):1305-10.სრული ტექსტი  აბსტრაქტი

Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-15. აბსტრაქტი

Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016 Feb;14(2):175-82.სრული ტექსტი  აბსტრაქტი

1. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2022 Jan 1;117(1):27-56.სრული ტექსტი  აბსტრაქტი

2. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006 Aug;101(8):1900-20. აბსტრაქტი

3. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association medical position statement on the management of gastroesophageal reflux disease. Gastroenterology. 2008;135:1383-91.სრული ტექსტი  აბსტრაქტი

4. Sidhwa F, Moore A, Alligood E, et al. Diagnosis and treatment of the extraesophageal manifestations of gastroesophageal reflux disease. Ann Surg. 2017 Jan;265(1):63-7. აბსტრაქტი

5. Fass R. Gastroesophageal reflux disease. N Engl J Med. 2022 Sep 29;387(13):1207-16. აბსტრაქტი

6. Chen JW, Vela MF, Peterson KA, et al. AGA clinical practice update on the diagnosis and management of extraesophageal gastroesophageal reflux disease: expert review. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1414-21.e3.სრული ტექსტი  აბსტრაქტი

7. Gerson LB, Kahrilas PJ, Fass R. Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol. 2011 Oct;9(10):824-33.სრული ტექსტი  აბსტრაქტი

8. Hungin APS, Molloy-Bland M, Scarpignato C. Revisiting Montreal: New Insights into Symptoms and Their Causes, and Implications for the Future of GERD. Am J Gastroenterol. 2019 Mar;114(3):414-21.სრული ტექსტი  აბსტრაქტი

9. Savarino E, Bredenoord AJ, Fox M, et al. Expert consensus document: advances in the physiological assessment and diagnosis of GERD. Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):665-76.სრული ტექსტი  აბსტრაქტი

10. DeVault KR. Extraesophageal symptoms of GERD. Cleve Clin J Med. 2003 Nov;70 Suppl 5:S20-S32. აბსტრაქტი

11. Malfertheiner SF, Malfertheiner MV, Kropf S, et al. A prospective longitudinal cohort study: evolution of GERD symptoms during the course of pregnancy. BMC Gastroenterol. 2012 Sep 24;12:131.სრული ტექსტი  აბსტრაქტი

12. Dunbar K, Yadlapati R, Konda V. Heartburn, nausea, and vomiting during pregnancy. Am J Gastroenterol. 2022 Oct 1;117(10s):10-15.სრული ტექსტი  აბსტრაქტი

13. Richter JE. Review article: the management of heartburn in pregnancy. Aliment Pharmacol Ther. 2005 Nov 1;22(9):749-57.სრული ტექსტი  აბსტრაქტი

14. Van Thiel DH, Gavaler JS, Joshi SN, et al. Heartburn of pregnancy. Gastroenterology. 1977 Apr;72(4 pt 1):666-8. აბსტრაქტი

15. El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2013 Jul 13;63(6):871-80. აბსტრაქტი

16. Eusebi LH, Ratnakumaran R, Yuan Y, et al. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut. 2018 Mar;67(3):430-40. აბსტრაქტი

17. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005 Aug 2;143(3):199-211. აბსტრაქტი

18. Kim KJ, Lee BS. Central obesity as a risk factor for non-erosive reflux disease. Yonsei Med J. 2017 Jul;58(4):743-8. აბსტრაქტი

19. Lembo A, Zaman M, Jones M, et al. Influence of genetics on irritable bowel syndrome, gastro-oesophageal reflux and dyspepsia: a twin study. Aliment Pharmacol Ther. 2007 Jun 1;25(11):1343-50.სრული ტექსტი  აბსტრაქტი

20. Lagergren J, Bergstrom R, Adams HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med. 2000 Aug 1;133(3):165-75. აბსტრაქტი

21. Katzka DA, Kahrilas PJ. Advances in the diagnosis and management of gastroesophageal reflux disease. BMJ. 2020 Nov 23;371:m3786. აბსტრაქტი

22. Holloway RH, Lyrenas E, Ireland A, et al. Effect of intraduodenal fat on lower oesophageal sphincter function and gastro-oesophageal reflux. Gut. 1997 Apr;40(4):449-53.სრული ტექსტი  აბსტრაქტი

23. Katzka DA, Sidhu M, Castell DO. Hypertensive lower esophageal sphincter pressures and gastroesophageal reflux: an apparent paradox that is not unusual. Am J Gastroenterol. 1995 Feb;90(2):280-4. აბსტრაქტი

24. Abou-Ismail A, Vaezi MF. Evaluation of patients with suspected laryngopharyngeal reflux: a practical approach. Curr Gastroenterol Rep. 2011 Jun;13(3):213-8. აბსტრაქტი

25. American Lung Association Asthma Clinical Research Centers, Mastronarde JG, Anthonisen NR, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009 Apr 9;360(15):1487-99. აბსტრაქტი

26. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2024 [internet publication].სრული ტექსტი

27. Locke GR III, Talley NJ, Fett SL, et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999 Jun;106(6):642-9. აბსტრაქტი

28. Mittal RK, Lange RC, McCallum RW. Identification and mechanism of delayed esophageal acid clearance in subjects with hiatus hernia. Gastroenterology. 1987 Jan;92(1):130-5.სრული ტექსტი  აბსტრაქტი

29. Sloan S, Kahrilas PJ. Impairment of esophageal emptying with hiatal hernia. Gastroenterology. 1991 Mar;100(3):596-605.სრული ტექსტი  აბსტრაქტი

30. Broers C, Tack J, Pauwels A. Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease. Aliment Pharmacol Ther. 2017 Jan;47(2):176-91.სრული ტექსტი  აბსტრაქტი

31. Pan J, Cen L, Chen W, et al. Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis. Alcohol Alcohol. 2019 Jan 1;54(1):62-9.სრული ტექსტი  აბსტრაქტი

32. Nirwan JS, Hasan SS, Babar ZU, et al. Global prevalence and risk factors of gastro-oesophageal reflux disease (GORD): systematic review with meta-analysis. Sci Rep. 2020 Apr 2;10(1):5814.სრული ტექსტი  აბსტრაქტი

33. Repici A, Fuccio L, Maselli R, et al. GERD after per-oral endoscopic myotomy as compared with Heller's myotomy with fundoplication: a systematic review with meta-analysis. Gastrointest Endosc. 2018 Apr;87(4):934-43. აბსტრაქტი

34. Surdea-Blaga T, Negrutiu DE, Palage M, et al. Food and Gastroesophageal Reflux Disease. Curr Med Chem. 2019;26(19):3497-511. აბსტრაქტი

35. Terry P, Lagergren J, Wolk A, et al. Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer. 2000;38(2):186-91. აბსტრაქტი

36. Yadlapati R, Gyawali CP, Pandolfino JE, et al. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol. 2022 May;20(5):984-94.e1.სრული ტექსტი  აბსტრაქტი

37. Muthusamy VR, Lightdale JR, Acosta RD, et al; ASGE Standards of Practice Committee. The role of endoscopy in the management of GERD. Gastrointest Endosc. 2015;81(6):1305-10.სრული ტექსტი  აბსტრაქტი

38. Sharma P, Wani S, Rastogi A, et al. The diagnostic accuracy of esophageal capsule endoscopy: a blinded, prospective study. Am J Gastroenterol. 2008 Mar;103(3):525-32. აბსტრაქტი

39. Eliakim R, Sharma VK, Yassin K, et al. A prospective study of the diagnostic accuracy of PillCam ESO esophageal capsule endoscopy versus conventional upper endoscopy in patients with chronic gastroesophageal reflux diseases. J Clin Gastroenterol. 2005 Aug;39(7):572-8. აბსტრაქტი

40. Bhardwaj A, Hollenbeak CS, Pooran N. A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy. Am J Gastroenterol. 2009 Jun;104(6):1533-9. აბსტრაქტი

41. Hirano I, Richter JE; Practice Parameters Committee of the American College of Gastroenterology. ACG Practice Guidelines: esophageal reflux testing. Am J Gastroenterol. 2007 Mar;102(3):668-85.სრული ტექსტი  აბსტრაქტი

42. Levine MS, Carucci LR, DiSantis DJ, et al. Consensus statement of Society of Abdominal Radiology disease-focused panel on barium esophagography in gastroesophageal reflux disease. AJR Am J Roentgenol. 2016 Nov;207(5):1009-15.სრული ტექსტი  აბსტრაქტი

43. Di Fede O, Di Liberto C, Occhipinti G, et al. Oral manifestations in patients with gastro-oesophageal reflux disease: a single-center case-control study. J Oral Pathol Med. 2008 Jul;37(6):336-40. აბსტრაქტი

44. Eusebi LH, Ratnakumaran R, Bazzoli F, et al. Prevalence of dyspepsia in individuals with gastroesophageal reflux-type symptoms in the community: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017 Jan;16(1):39-48.სრული ტექსტი  აბსტრაქტი

45. Vaezi MF, Pandolfino JE, Vela MF, et al. White paper AGA: optimal strategies to define and diagnose gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2017 Aug;15(8):1162-72.სრული ტექსტი  აბსტრაქტი

46. Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med. 2008 Oct 16;359(16):1700-7. აბსტრაქტი

47. Gyawali CP, Kahrilas PJ, Savarino E, et al. Modern diagnosis of GERD: the Lyon Consensus. Gut. 2018 Jul;67(7):1351-62.სრული ტექსტი  აბსტრაქტი

48. Trudgill NJ, Sifrim D, Sweis R, et al. British Society of Gastroenterology guidelines for oesophageal manometry and oesophageal reflux monitoring. Gut. 2019 Oct;68(10):1731-50.სრული ტექსტი  აბსტრაქტი

49. Hemmink GJ, Bredenoord AJ, Weusten BL, et al. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor? Am J Gastroenterol. 2008 Oct;103(10):2446-53. აბსტრაქტი

50. Kahrilas PJ, Sifrim D. High-resolution manometry and impedance-pH/manometry: valuable tools in clinical and investigational esophagology. Gastroenterol. 2008 Sep;135(3):756-69. აბსტრაქტი

51. Ravi K, Katzka DA. Esophageal impedance monitoring: clinical pearls and pitfalls. Am J Gastroenterol. 2016 Sep;111(9):1245-56. აბსტრაქტი

52. Hirano I, Pandolfino JE, Boeckxstaens GE. Functional Lumen Imaging Probe for the Management of Esophageal Disorders: Expert Review From the Clinical Practice Updates Committee of the AGA Institute. Clin Gastroenterol Hepatol. 2017 Mar;15(3):325-34.სრული ტექსტი  აბსტრაქტი

53. Moayyedi P, Lacy BE, Andrews CN, et al. ACG and CAG clinical guideline: management of dyspepsia. Am J Gastroenterol. 2017 Jul;112(7):988-1013. აბსტრაქტი

54. Dellon ES, Gonsalves N, Hirano I, et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol. 2013 May;108(5):679-92. აბსტრაქტი

55. Dellon ES, Liacouras CA, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis: proceedings of the AGREE conference. Gastroenterology. 2018 Oct;155(4):1022-33.სრული ტექსტი  აბსტრაქტი

56. Lechien JR, Akst LM, Hamdan AL, et al. Evaluation and management of laryngopharyngeal reflux disease: state of the art review. Otolaryngol Head Neck Surg. 2019 May;160(5):762-82. აბსტრაქტი

57. Guo H, Ma H, Wang J. Proton pump inhibitor therapy for the treatment of laryngopharyngeal reflux: a meta-analysis of randomized controlled trials. J Clin Gastroenterol. 2016 Apr;50(4):295-300. აბსტრაქტი

58. Storr MA. What is nonacid reflux disease? Can J Gastroenterol. 2011 Jan;25(1):35-8.სრული ტექსტი  აბსტრაქტი

59. McCabe ME 4th, Dilly CK. New causes for the old problem of bile reflux gastritis. Clin Gastroenterol Hepatol. 2018 Sep;16(9):1389-92.სრული ტექსტი  აბსტრაქტი

60. Armstrong D, Marshall JK, Chiba N, et al; Canadian Association of Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004. Can J Gastroenterol. 2005 Jan;19(1):15-35. აბსტრაქტი

61. Armstrong D, Bennett JR, Blum AL, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996Jul;111(1):85-92. აბსტრაქტი

62. Wang WH, Huang JQ, Zheng GF, et al. Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol. 2005 Jul 14;11(26):4067-77.სრული ტექსტი  აბსტრაქტი

63. Freedberg DE, Kim LS, Yang YX. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology. 2017 Mar;152(4):706-15. აბსტრაქტი

64. Shiraev TP, Bullen A. Proton pump inhibitors and cardiovascular events: a systematic review. Heart Lung Circ. 2017 Apr;27(4):443-50. აბსტრაქტი

65. Mehta RS, Nguyen LH, Ma W, et al. Association of diet and lifestyle with the risk of gastroesophageal reflux disease symptoms in US women. JAMA Intern Med. 2021 Apr 1;181(4):552-4.სრული ტექსტი  აბსტრაქტი

66. Ness-Jensen E, Hveem K, El-Serag H, et al. Lifestyle intervention in gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2016 Feb;14(2):175-82.სრული ტექსტი  აბსტრაქტი

67. Gu C, Olszewski T, King KL, et al. The effects of modifying amount and type of dietary carbohydrate on esophageal acid exposure time and esophageal reflux symptoms: a randomized controlled trial. Am J Gastroenterol. 2022 Oct 1;117(10):1655-67.სრული ტექსტი  აბსტრაქტი

68. National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. Oct 2019 [internet publication].სრული ტექსტი

69. Hunt R, Armstrong D, Katelaris P, et al. World Gastroenterology Organisation global guidelines: GERD global perspective on gastroesophageal reflux disease. J Clin Gastroenterol. 2017 Jul;51(6):467-78. აბსტრაქტი

70. Ichikawa H, Sugimoto M, Sugimoto K, et al. Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis. J Gastroenterol Hepatol. 2016 Apr;31(4):716-26. აბსტრაქტი

71. Haastrup P, Paulsen MS, Begtrup LM, et al. Strategies for discontinuation of proton pump inhibitors: a systematic review. Fam Pract. 2014 Dec;31(6):625-30.სრული ტექსტი  აბსტრაქტი

72. Boghossian TA, Rashid FJ, Thompson W, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database Syst Rev. 2017 Mar 16;(3):CD011969.სრული ტექსტი  აბსტრაქტი

73. Finks JF, Wei Y, Birkmeyer JD. The rise and fall of antireflux surgery in the United States. Surg Endosc. 2006 Nov;20(11):1698-701.სრული ტექსტი  აბსტრაქტი

74. Khan F, Maradey-Romero C, Ganocy S, et al. Utilisation of surgical fundoplication for patients with gastro-oesophageal reflux disease in the USA has declined rapidly between 2009 and 2013. Aliment Pharmacol Ther. 2016 Jun;43(11):1124-31.სრული ტექსტი  აბსტრაქტი

75. University of Michigan Health System. Gastroesophageal reflux disease (GERD). May 2012 [internet publication].სრული ტექსტი

76. Slater BJ, Dirks RC, McKinley SK, et al. SAGES guidelines for the surgical treatment of gastroesophageal reflux (GERD). Surg Endosc. 2021 Sep;35(9):4903-17 აბსტრაქტი

77. Fuchs KH, Babic B, Breithaupt W, et al. EAES recommendations for the management of gastroesophageal reflux disease. Surg Endosc. 2014;28:1753-73. აბსტრაქტი

78. Slater BJ, Collings A, Dirks R, et al. Multi-society consensus conference and guideline on the treatment of gastroesophageal reflux disease (GERD). Surg Endosc. 2023 Feb;37(2):781-806. აბსტრაქტი

79. Garg SK, Gurusamy KS. Laparoscopic fundoplication surgery versus medical management for gastro-oesophageal reflux disease (GORD) in adults. Cochrane Database Syst Rev. 2015 Nov 5;(11):CD003243.სრული ტექსტი  აბსტრაქტი

80. Rickenbacher N, Kötter T, Kochen MM, et al. Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis. Surg Endosc. 2014 Jan;28(1):143-55. აბსტრაქტი

81. Peters MJ, Mukhtar A, Yunus RM, et al. Meta-analysis of randomized clinical trials comparing open and laparoscopic anti-reflux surgery. Am J Gastroenterol. 2009 Jun;104(6):1548-62. აბსტრაქტი

82. Qu H, Liu Y, He QS. Short- and long-term results of laparoscopic versus open anti-reflux surgery: a systematic review and meta-analysis of randomized controlled trials. J Gastrointest Surg. 2014 Jun;18(6):1077-86. აბსტრაქტი

83. Du X, Hu Z, Yan C, et al. A meta-analysis of long follow-up outcomes of laparoscopic Nissen (total) versus Toupet (270°) fundoplication for gastro-esophageal reflux disease based on randomized controlled trials in adults. BMC Gastroenterol. 2016 Aug 2;16(1):88.სრული ტექსტი  აბსტრაქტი

84. Maret-Ouda J, Wahlin K, El-Serag HB, et al. Association between laparoscopic antireflux surgery and recurrence of gastroesophageal reflux. JAMA. 2017 Sep 12;318(10):939-46. აბსტრაქტი

85. Amer MA, Smith MD, Khoo CH, et al. Network meta-analysis of surgical management of gastro-oesophageal reflux disease in adults. Br J Surg. 2018 Oct;105(11):1398-407. აბსტრაქტი

86. Bashir Y, Chonchubhair HN, Duggan SN, et al. Systematic review and meta-analysis on the effect of obesity on recurrence after laparoscopic anti-reflux surgery. Surgeon. 2019 Apr;17(2):107-18.სრული ტექსტი  აბსტრაქტი

87. Abdelrahman T, Latif A, Chan DS, et al. Outcomes after laparoscopic anti-reflux surgery related to obesity: A systematic review and meta-analysis. Int J Surg. 2018 Mar;51:76-82.სრული ტექსტი  აბსტრაქტი

88. Tandon A, Rao R, Hotouras A, et al. Safety and effectiveness of antireflux surgery in obese patients. Ann R Coll Surg Engl. 2017 Sep;99(7):515-23.სრული ტექსტი  აბსტრაქტი

89. Richter JE, Kumar A, Lipka S, et al. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis. Gastroenterology. 2018 Apr;154(5):1298-1308.e7.სრული ტექსტი  აბსტრაქტი

90. Stefanidis G, Viazis N, Kotsikoros N, et al. Long-term benefit of transoral incisionless fundoplication using the esophyx device for the management of gastroesophageal reflux disease responsive to medical therapy. Dis Esophagus. 2017 Feb 1;30(3):1-8.სრული ტექსტი  აბსტრაქტი

91. McCarty TR, Itidiare M, Njei B, et al. Efficacy of transoral incisionless fundoplication for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endoscopy. 2018 Jul;50(7):708-25. აბსტრაქტი

92. Garg R, Mohammed A, Singh A, et al. Anti-reflux mucosectomy for refractory gastroesophageal reflux disease: a systematic review and meta-analysis. Endosc Int Open. 2022 Jun;10(6):E854-64.სრული ტექსტი  აბსტრაქტი

93. Inoue H, Tanabe M, de Santiago ER, et al. Anti-reflux mucosal ablation (ARMA) as a new treatment for gastroesophageal reflux refractory to proton pump inhibitors: a pilot study. Endosc Int Open. 2020 Feb;8(2):E133-8.სრული ტექსტი  აბსტრაქტი

94. Chou CK, Chen CC, Chen CC, et al. Positive and negative impact of anti-reflux mucosal intervention on gastroesophageal reflux disease. Surg Endosc. 2023 Feb;37(2):1060-9. აბსტრაქტი

95. Madalosso CA, Gurski RR, Callegari-Jacques SM, et al. The impact of gastric bypass on gastroesophageal reflux disease in patients with morbid obesity: a prospective study based on the Montreal Consensus. Ann Surg. 2010 Feb;251(2):244-8. აბსტრაქტი

96. Gu L, Chen B, Du N, et al. Relationship Between Bariatric Surgery and Gastroesophageal Reflux Disease: a Systematic Review and Meta-analysis. Obes Surg. 2019 Dec;29(12):4105-13. აბსტრაქტი

97. Ali M, El Chaar M, Ghiassi S, et al. American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2017 Oct;13(10):1652-7. აბსტრაქტი

98. Ali RAR, Hassan J, Egan LJ. Review of recent evidence on the management of heartburn in pregnant and breastfeeding women. BMC Gastroenterol. 2022 May 4;22(1):219.სრული ტექსტი  აბსტრაქტი

99. Rohof WO, Bennink RJ, Smout AJ, et al. An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2013 Dec;11(12):1585-e90.სრული ტექსტი  აბსტრაქტი

100. Hampson FC, Jolliffe IG, Bakhtyari A, et al. Alginate-antacid combinations: raft formation and gastric retention studies. Drug Dev Ind Pharm. 2010 May;36(5):614-23. აბსტრაქტი

101. Thélin CS, Richter JE. Review article: the management of heartburn during pregnancy and lactation. Aliment Pharmacol Ther. 2020 Feb;51(4):421-34. აბსტრაქტი

102. Farrell B, Lass E, Moayyedi P, et al. Reduce unnecessary use of proton pump inhibitors. BMJ. 2022 Oct 24;379:e069211. აბსტრაქტი

103. Koggel LM, Lantinga MA, Büchner FL, et al. Predictors for inappropriate proton pump inhibitor use: observational study in primary care. Br J Gen Pract. 2022 Dec;72(725):e899-906.სრული ტექსტი  აბსტრაქტი

104. Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology. 2022 Apr;162(4):1334-42.სრული ტექსტი  აბსტრაქტი

105. Chen J, Yuan YC, Leontiadis GI, et al. Recent safety concerns with proton pump inhibitors. J Clin Gastroenterol. 2012 Feb;46(2):93-114. აბსტრაქტი

106. Savarino E, Anastasiou F, Labenz J, et al. Holistic management of symptomatic reflux: rising to the challenge of proton pump inhibitor overuse. Br J Gen Pract. 2022 Nov;72(724):541-4.სრული ტექსტი  აბსტრაქტი

107. Xie Y, Bowe B, Yan Y, et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ. 2019 May 29;365:l1580.სრული ტექსტი  აბსტრაქტი

108. Poly TN, Islam MM, Yang HC, et al. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies. Osteoporos Int. 2019 Jan;30(1):103-14. აბსტრაქტი

109. Chrysant SG. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias. Expert Rev Cardiovasc Ther. 2019 May;17(5):345-51. აბსტრაქტი

110. Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011 Apr;56(4):931-50.სრული ტექსტი  აბსტრაქტი

111. Heidelbaugh JJ, Kim AH, Chang R, et al. Overutilization of proton-pump inhibitors: what the clinician needs to know. Therap Adv Gastroenterol. 2012 Jul;5(4):219-32. აბსტრაქტი

112. Wilhelm SM, Rjater RG, Kale-Pradhan PB. Perils and pitfalls of long-term effects of proton pump inhibitors. Expert Rev Clin Pharmacol. 2013 Jul;6(4):443-51. აბსტრაქტი

113. Abrahami D, McDonald EG, Schnitzer ME, et al. Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut. 2022 Jan;71(1):16-24.სრული ტექსტი  აბსტრაქტი

114. Moayyedi P, Eikelboom JW, Bosch J, et al. Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin. Gastroenterology. 2019 Sep;157(3):682-91.e2.სრული ტექსტი  აბსტრაქტი

115. Kinoshita Y, Kato M, Fujishiro M, et al. Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: the Japan-based EXTEND study. J Gastroenterol. 2018 Jul;53(7):834-44. აბსტრაქტი

116. Lundell L, Attwood S, Ell C, et al. Comparing laparoscopic antireflux surgery with esomeprazole in the management of patients with chronic gastro-oesophageal reflux disease: a 3-year interim analysis of the LOTUS trial. Gut. 2008 Sep;57(9):1207-13.სრული ტექსტი  აბსტრაქტი

117. Caos A, Breiter J, Perdomo C, et al. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States. Aliment Pharmacol Ther. 2005 Aug 1;22(3):193-202.სრული ტექსტი  აბსტრაქტი

118. Galmiche JP, Hatlebakk J, Attwood S, et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA. 2011 May 18;305(19):1969-77.სრული ტექსტი  აბსტრაქტი

119. Yuan J, He Q, Nguyen LH, et al. Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies. Gut. 2021 Jun;70(6):1070-7. აბსტრაქტი

120. Ciardullo S, Rea F, Savaré L, et al. Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study. J Clin Endocrinol Metab. 2022 Jun 16;107(7):e2671-e2679.სრული ტექსტი  აბსტრაქტი

121. Chiba N, De Gara CJ, Wilkinson JM, et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology. 1997 Jun;112(6):1798-810. აბსტრაქტი

122. Laine L, DeVault K, Katz P, et al. Vonoprazan versus lansoprazole for healing and maintenance of healing of erosive esophagitis: a randomized trial. Gastroenterology. 2023 Jan;164(1):61-71.სრული ტექსტი  აბსტრაქტი

123. Xiao Y, Zhang S, Dai N, et al. Phase III, randomised, double-blind, multicentre study to evaluate the efficacy and safety of vonoprazan compared with lansoprazole in Asian patients with erosive oesophagitis. Gut. 2020 Feb;69(2):224-30.სრული ტექსტი  აბსტრაქტი

124. Witteman BP, Conchillo JM, Rinsma NF, et al. Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol. 2015 Apr;110(4):531-42. აბსტრაქტი

125. Shaheen NJ, Falk GW, Iyer PG, et al. Diagnosis and management of barrett's esophagus: an updated ACG guideline. Am J Gastroenterol. 2022 Apr 1;117(4):559-87.სრული ტექსტი  აბსტრაქტი